Peptide Guide + Calculator

Kisspeptin Reconstitution Calculator & Guide

Kisspeptin-10 / Kisspeptin-54 / KISS1R Agonist

Kisspeptin is a family of naturally occurring reproductive neuropeptides that stimulate the hypothalamic-pituitary-gonadal axis primarily by activating KISS1R and promoting endogenous GnRH signaling. Human studies show clear effects on LH and FSH release, and kisspeptin-54 has been studied as an investigational trigger for oocyte maturation in IVF. Kisspeptin products sold online are not FDA-approved therapies, and FDA has identified safety and characterization concerns for compounded kisspeptin-10.

Evidence Snapshot

Kisspeptin research at a glance

Standardized regulatory and evidence context so research compounds, investigational drugs, and approved medications are not treated as if they have the same level of human evidence.

Reviewed Sep 7, 2026

Regulatory status

Not FDA-approved

Development / evidence stage

Early clinical / human pharmacology

Human evidence level

Human pharmacology / early clinical

Primary mechanism

KISS1R agonist that acts upstream of GnRH neurons to stimulate reproductive-axis signaling.

WADA context

Explicitly prohibited — S2 (male athletes)

Primary targets

KISS1R / GPR54Upstream GnRH signaling

What is a receptor?

Human intervention evidence

Kisspeptin-54 has been studied as an investigational trigger for oocyte maturation during IVF, and kisspeptin-10 has controlled human physiology data including a 2026 chronic-administration study in healthy men.

Human biology evidence

Multiple controlled human studies show that kisspeptin can stimulate LH and FSH secretion, with responses varying by sex, reproductive state, isoform, and administration pattern.

Key takeaway

Kisspeptin has real human reproductive-endocrinology evidence, but it remains investigational and should not be treated as an approved testosterone or fertility peptide.

Evidence labels describe the research base and regulatory context; they are not treatment, dosing, or use recommendations. Review dates describe the last BACToBasics source check for this evidence summary. Anti-doping rules can change and should be verified with the applicable authority.

Kisspeptin Reconstitution Calculator

Enter the vial amount, liquid volume, and amount you want to calculate. BACToBasics will automatically calculate concentration, liquid volume, and U-100 syringe-unit equivalents.

Loading calculator...

Calculator values are educational math inputs only. They are not recommended preparation amounts, doses, or use protocols.

Kisspeptin Reconstitution Math

Reconstitution math starts with the amount contained in the vial and the liquid volume used in the calculation. Dividing the vial amount by the liquid volume gives the resulting concentration.

Example vial amount

1 mg

Liquid VolumeCalculationConcentration
1 mL1 mg ÷ 1 mL1 mg/mL
2 mL1 mg ÷ 2 mL0.5 mg/mL
3 mL1 mg ÷ 3 mL0.3333 mg/mL

This table demonstrates concentration math only. The liquid volumes shown are examples for comparison and are not preparation recommendations.

More Reconstitution Tools

Need to compare different liquid volumes or convert between mg, mcg, mL, and U-100 units? Use the dedicated BACToBasics calculator tools.

What is kisspeptin?

Kisspeptins are peptide products of the KISS1 gene. They bind the KISS1 receptor, also called GPR54, and are major upstream regulators of reproductive hormone signaling. In humans, kisspeptin signaling helps control GnRH release from the hypothalamus, which in turn drives pituitary secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

Kisspeptin-10 vs kisspeptin-54

Kisspeptin-10 and kisspeptin-54 are related members of the same peptide family rather than interchangeable formulations. Both can stimulate reproductive hormone release in human studies, but their pharmacokinetics, duration of action, and study designs differ. Research findings for one isoform should not automatically be applied to every product labeled simply as 'kisspeptin.'

What does kisspeptin do to LH and FSH?

Controlled human physiology studies show that kisspeptin can increase gonadotropin secretion. In healthy men, kisspeptin-10 increased LH and FSH, and direct comparison studies found that GnRH produced a larger gonadotropin response than kisspeptin at the tested intravenous doses. Responses in women vary with reproductive state and cycle phase.

Kisspeptin and IVF research

Kisspeptin-54 has been investigated as a trigger for final oocyte maturation during IVF. Early clinical studies showed that it could induce an LH surge, oocyte maturation, fertilization, and pregnancy in studied populations. These investigational findings do not make kisspeptin an FDA-approved fertility treatment.

Does kisspeptin stop working with repeated exposure?

The answer depends on the isoform and administration pattern. Earlier work found tachyphylaxis with repeated kisspeptin-54 exposure in women with hypothalamic amenorrhea, while a 2026 controlled study in healthy men found that intermittent subcutaneous kisspeptin-10 infusions could sustain gonadotropin stimulation over 12 days. These findings show why schedule-specific research should not be simplified into a universal claim.

Is kisspeptin FDA-approved?

No kisspeptin drug is FDA-approved for fertility, testosterone support, hormone restoration, or general wellness. FDA lists kisspeptin-10 among bulk substances that raise significant safety concerns for compounding, citing potential immunogenicity, peptide-related impurities, API-characterization complexity, and limited safety information for proposed routes of administration.

Kisspeptin vs gonadorelin

Kisspeptin acts upstream of endogenous GnRH signaling, while gonadorelin is synthetic GnRH itself and directly stimulates pituitary GnRH receptors. Human comparison data support this mechanistic distinction: both can increase gonadotropins, but GnRH was more potent at the doses tested in one controlled study. BACToBasics provides a dedicated side-by-side comparison rather than treating them as interchangeable.

Anti-doping status

The 2026 WADA Prohibited List names kisspeptin and its agonist analogues under S2.2.1 testosterone-stimulating peptides in males. Competitive athletes should verify current rules with the applicable anti-doping authority because prohibited-list wording can change.

Kisspeptin reconstitution math

The calculator on this page performs generic labeled-vial concentration, mL, and U-100 syringe-unit math from user-entered values. It does not recommend a kisspeptin dose, route, frequency, fertility protocol, or hormone-management regimen.

Explore more about Kisspeptin

7 links

Comparisons, research records, development tracking, blends, and related guides are available here when you want to go deeper.

Kisspeptin FAQ

Tap a question to expand only the answer you want to read.

Is kisspeptin the same as GnRH?

No. Kisspeptin acts upstream and promotes endogenous GnRH signaling, while gonadorelin is synthetic GnRH itself.

Does kisspeptin increase LH?

Yes. Multiple human studies have shown increases in LH after kisspeptin administration, although the magnitude depends on sex, reproductive state, isoform, and study design.

Does kisspeptin increase testosterone?

In men, kisspeptin can stimulate the reproductive axis and has increased LH and testosterone in controlled research. That does not establish an approved testosterone-treatment protocol.

Is kisspeptin FDA-approved?

No. Kisspeptin is not FDA-approved as a fertility, testosterone, hormone-restoration, or wellness drug.

Has kisspeptin been studied in IVF?

Yes. Kisspeptin-54 has been studied as an investigational trigger for oocyte maturation in women undergoing IVF.

Is kisspeptin prohibited by WADA?

The 2026 WADA Prohibited List explicitly names kisspeptin and its agonist analogues under S2.2.1 for male athletes.

Can BACToBasics calculate kisspeptin vial math?

Yes. The calculator performs generic concentration, mL, and U-100 syringe-unit math from user-entered labeled values without recommending a dose or protocol.

Sources & References

6 sources

Open the references when you want to inspect the research and regulatory sources behind this guide.

1
U.S. FDA — Certain Bulk Drug Substances That May Present Significant Safety Risks

FDA compounding-safety page identifying immunogenicity, impurity, API-characterization, and limited-safety-data concerns for kisspeptin-10.

2
George et al. — Kisspeptin-10 Is a Potent Stimulator of LH in Men, 2011

Controlled human physiology study showing stimulation of LH and increased LH pulse frequency. PMID: 21632807.

3
Jayasena et al. — Direct Comparison of Kisspeptin-10, Kisspeptin-54 and GnRH, 2015

Human comparison study showing gonadotropin stimulation by both kisspeptin isoforms and greater response to GnRH at tested doses. PMID: 26089302.

4
Jayasena et al. — Kisspeptin-54 Triggers Egg Maturation During IVF, 2014

Clinical study showing oocyte maturation and subsequent pregnancies after investigational kisspeptin-54 administration. PMID: 25036713.

5
2026 Chronic Subcutaneous Kisspeptin-10 Study in Healthy Men

Randomized controlled physiology study evaluating acute, continuous, and intermittent kisspeptin-10 administration over as long as 12 days. PMID: 42549827.

6
WADA — 2026 Prohibited List

Lists kisspeptin and its agonist analogues under S2.2.1 testosterone-stimulating peptides in males.

BACToBasics provides educational information and math tools only. This content is not medical advice, dosing advice, injection instruction, or a recommendation to use any peptide or medication.